Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9HAU4
UPID:
SMUF2_HUMAN
Alternative names:
HECT-type E3 ubiquitin transferase SMURF2; SMAD ubiquitination regulatory factor 2; SMAD-specific E3 ubiquitin-protein ligase 2
Alternative UPACC:
Q9HAU4; Q52LL1; Q9H260
Background:
E3 ubiquitin-protein ligase SMURF2 plays a pivotal role in cellular processes by transferring ubiquitin to substrates, affecting their degradation and signaling pathways. It regulates TGF-beta signaling through interaction with SMAD7, leading to SMAD7-mediated receptor degradation. Additionally, SMURF2 targets SMAD1 and SMAD2 for degradation, modulating their activity in cellular processes. Its interaction with viral proteins, such as Ebola's VP40, highlights its role in microbial infection by facilitating virus budding.
Therapeutic significance:
Understanding the role of E3 ubiquitin-protein ligase SMURF2 could open doors to potential therapeutic strategies. Its involvement in TGF-beta signaling and interaction with viral proteins presents it as a target for therapeutic intervention in diseases related to these pathways.